Abstract
Background and Objectives:Catabolism and growth impairment are well-known complications of inflammatory bowel disease (IBD). Recent studies have demonstrated significant changes in the IGF system in IBD patients. The aim of the present study was to investigate correlations between the IGF system and markers of inflammation in IBD. Methods:A cross-sectional study comprising 99 IBD patients (Crohn’s disease (CD, n = 50) and ulcerative colitis (UC, n = 49)). Correlations between markers of inflammation and IGF-I, IGF-II and IGFBP-3 were examined in CD and UC patients in remission and relapse. The patients were clinically scored using Crohn’s Disease Activity Index (CDAI) for CD patients and Activity Index (AI) for UC patients. Results: In the UC group we found correlations between IGF-I and CRP (r<sub>s</sub> = Spearman’s rho) (r<sub>s</sub> = –0.40, p < 0.01) and albumin (r<sub>s</sub> = 0.46, p < 0.001), IGFBP-3 and albumin (r<sub>s</sub> = 0.36, p < 0.01) and AI score (r<sub>s</sub> = –0.31, p < 0.05). IGF-II correlated with CRP (r<sub>s</sub> = –0.42, p < 0.01), IL-6 (r<sub>s</sub> = –0.65, p < 0.001), albumin (r<sub>s</sub> = 0.41, p < 0.01), AI score (r<sub>s</sub> = –0.30, p < 0.05) and orosomucoid (r<sub>s</sub> = –0.47, p < 0.001). In the CD group we found correlations between IGF-I and CRP (r<sub>s</sub> = –0.40, p < 0.05), and albumin (r<sub>s</sub> = –0.46, p < 0.01), IGFBP-3 and albumin (r = 0.36, p < 0.01). IGF-II correlated with IL-6 (r<sub>s</sub> = –0.65, p < 0.001), albumin (r<sub>s</sub> = 0.41, p < 0.01), CDAI score (r<sub>s</sub> = –0.30, p < 0.05) and orosomucoid (r<sub>s</sub> = –0.47, p < 0.001). Conclusions: IGF-I, IGF-II and IGFBP-3 are correlated to albumin and IGF-I and IGF-II are correlated to CRP in IBD patients. Further, IGF-II is correlated to IL-6 in IBD patients. This may suggest a correlation between inflammation and the IGF system with involvement in muscle and bone catabolism in IBD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
